Nonprofit · EIN 20-3654626
REGENERATIVE RESEARCH FOUNDATION
Tax-exempt · ALBANY, NY 12208
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $7,965,326 | $7,076,763 | $888,563 | $10,216,177 | $3,299,474 | $6,916,703 |
| December 31, 2024 | 990 | $7,006,538 | $6,491,048 | $515,490 | $9,028,494 | $3,000,354 | $6,028,140 |
| December 31, 2023 | 990 | $8,795,245 | $7,305,106 | $1,490,139 | $6,996,425 | $1,483,775 | $5,512,650 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $7,396,591
- of which government grants
- $6,596,455
- Program service revenue
- $250,843
- Investment income
- $133,890
- Royalties
- $13,133
- Other revenue
- $184,002
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $248,005
- Other salaries and wages
- $2,249,323
- Salaries, compensation and benefits (total)
- $2,978,732
- Professional fundraising fees
- $0
- Legal fees
- $153,332
- Accounting fees
- $23,820
- Occupancy
- $370,668
- Travel
- $25,714
- Depreciation
- $203,526
- Program services (functional)
- $6,129,093
- Management and general (functional)
- $938,337
- Fundraising (functional)
- $9,333
Balance sheet and other
- Total assets, start of year
- $9,028,494
- Total assets, end of year
- $10,216,177
- Total liabilities, end of year
- $3,299,474
- Net assets, end of year
- $6,916,703
- Land, buildings and equipment
- $634,043
- Net assets without donor restrictions
- $5,709,885
- Net assets with donor restrictions
- $1,206,818
- Gross receipts
- $7,965,326
- Employees
- 43
- Volunteers
- 16
- Year formed
- 2005
- State of legal domicile
- NY
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| SALLY TEMPLE-STERN PHD | EXECUTIVE & SCIENTIFIC DIRECTOR Officer | 65 | $170,986 | $23,994 |
| GLENNA FORD | PROJECT MANAGER Highest-paid employee | 40 | $139,103 | $14,462 |
| THOMAS KIEHL | PRINCIPAL INVESTIGATOR Highest-paid employee | 40 | $131,142 | $14,051 |
| CAITLIN HILL | PRINCIPAL INVESTIGATOR Highest-paid employee | 40 | $136,509 | $5,174 |
| TAYLOR BERTUCCI PHD | PRINCIPAL INVESTIGATOR Highest-paid employee | 40 | $102,614 | $3,505 |
| DAVID BUTLER PHD | PRINCIPAL INVESTIGATOR Highest-paid employee | 40 | $101,617 | $4,037 |
| JEFFREY H STERN MD PHD | DIRECTOR FOR TRANSLATIONAL RESEARCH Trustee or director, Officer | 30 | $53,025 | $0 |
| WILLIAM KAHN CPA | CHAIR Trustee or director, Officer | 5 | $0 | $0 |
| VITO GRASSO MPA CAE | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAVID O CARPENTER MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAWN ABBUHL | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBERT CATALANO MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| AMY G KLANN PHD JD | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2024: 13 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| SALLY TEMPLE-STERN PHD | SCIENTIFIC & EXECUTIVE DIR Officer | 65 | $173,942 | $21,897 |
| GLENNA FORD | CLINICAL TRIAL MANAGER Highest-paid employee | 40 | $139,694 | $15,319 |
| THOMAS KIEHL | PRINCIPAL INVESTIGATOR Highest-paid employee | 40 | $131,200 | $14,982 |
| CAITLIN HILL | PRINCIPAL INVESTIGATOR Highest-paid employee | 40 | $135,055 | $6,756 |
| DAVID BUTLER PHD | PRINCIPAL INVESTIGATOR Highest-paid employee | 60 | $101,541 | $5,314 |
| JEFFREY H STERN MD PHD | DIRECTOR FOR TRANSLATIONAL Trustee or director, Officer | 30 | $53,025 | $510 |
| WILLIAM KAHN CPA | CHAIR Trustee or director, Officer | 5 | $0 | $0 |
| JOHN WALSH | DIRECTOR Trustee or director | 1 | $0 | $0 |
| VITO GRASSO MPA CAE | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAVID O CARPENTER MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAWN ABBUHL | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBERT CATALANO MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| AMY G KLANN PHD JD | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 11 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| SALLY TEMPLE-STERN PHD | SCIENTIFIC & EXECUTIVE DIR Officer | 65 | $177,305 | $14,115 |
| CAITLIN HILL | PRINCIPAL INVESTIGATOR Highest-paid employee | 50 | $131,209 | $7,025 |
| THOMAS KIEHL | PRINCIPAL INVESTIGATOR Highest-paid employee | 50 | $116,681 | $13,916 |
| JEFFREY H STERN MD PHD | DIRECTOR FOR TRANSLATIONAL Trustee or director, Officer | 30 | $51,727 | $685 |
| WILLIAM KAHN CPA | CHAIR Trustee or director, Officer | 5 | $0 | $0 |
| JOHN WALSH | DIRECTOR Trustee or director | 2 | $0 | $0 |
| VITO GRASSO MPA CAE | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAVID O CARPENTER MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAWN ABBUHL | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBERT CATALANO MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| AMY G KLANN PHD JD | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 150 NEW SCOTLAND AVE, ALBANY, NY 12208-3423
- Principal officer (990 for 2025)
- WILLIAM KAHN CPA, 150 NEW SCOTLAND AVENUE, ALBANY, NY 12208
- Signed the 990
- WILLIAM KAHN CPA, CHAIR
- Phone
- (518) 694-8188
- Website
- WWW.NEURALSCI.ORG
- Return prepared by
- BST & CO CPAS LLP
Mission
THE PRINCIPAL MISSION OF THE REGENERATIVE RESEARCH FOUNDATION IS TO DEVELOP REGENERATIVE STEM CELL THERAPIES FOR DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS): THE BRAIN, SPINAL CORD, AND RETINA.
Program accomplishments
- DESPITE MANY CHALLENGES IN FISCAL YEAR 2025 THE REGENERATIVE RESEARCH FOUNDATION CONTINUED TO PURSUE ITS RESEARCH MISSION. DURING THE YEAR FOUNDATION RESEARCHERS PUBLISHED THIRTEEN ARTICLES IN PROMINENT SCIENTIFIC JOURNALS REPORTING THE RESULTS OF THEIR INVESTIGATIONS INTO NEURODEGENERATIVE DISEASES SUCH AS DEMENTIA, MACULAR DEGENERATION AND POTENTIAL TREATMENTS FOR NEURODEGENERATIVE DISEASES. THESE PUBLICATIONS ARE AVAILABLE TO THE RESEARCH COMMUNITY AND GENERAL PUBLIC FREE OF CHARGE THROUGH THE NATIONAL LIBRARY OF MEDICINE OPEN ACCESS REPOSITORY. THE FOUNDATION RESEARCHERS CONTINUE TO PREPARE FUNDING APPLICATIONS WHICH WILL SUPPORT THEIR RESEARCH ACTIVITIES. THE FOUNDATION CONTINUED TO DEVELOP AND IMPROVE ITS PRODUCTION OF HUMAN STEM CELL ORGANOID MODELS AS AN ALTERNATIVE TO THE USE OF ANIMAL MODELS. THESE EFFORTS ARE ENDORSED BY THE NIH AND FDA COMPLEMENT-ARIE INITIATIVES THAT PROMOTE NEW APPROACH METHODOLOGY (NAM) TO REDUCE ANIMAL USE IN DRUG DEVELOPMENT. THE FOUNDATION'S CORE FACILITY, NEURACELL, CONTINUES TO PROVIDE BRAIN REGION-SPECIFIC ORGANOIDS TO RESEARCHERS AROUND THE COUNTRY.Expenses $1,012,342
- THE CONTINUING PHASE 1/2A CLINICAL TRIAL TREATED ITS 12TH SUBJECT COMPLETING THE SECOND COHORT OF AN 18-SUBJECT TRIAL. THE FOUNDATION'S SCIENTIFIC DIRECTOR, DR. SALLY TEMPLE-STERN, DELIVERED THE CLOSING KEYNOTE ADDRESS AT THE 2026 ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY MEETING (THE MAJOR MEETING FOR OPHTHALMIC RESEARCH). THE SAFETY AND EFFICACY RESULTS OF THE LOW DOSE PHASE OF THE TRIAL WERE PUBLISHED DURING THE YEAR 2025.Expenses $1,013,548 · revenue $250,843
- THE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS RESEARCH PROGRAM CONTINUES ITS MISSION TO EXPAND THE UNDERSTANDING AND DEVELOPMENT OF A POTENTIAL TREATMENT FOR THESE NEURODEGENERATIVE DISEASES. THE INSTITUTE CONTINUES TO SERVE AS THE LEAD ORGANIZATION FOR A CONSORTIUM OF INSTITUTIONS AND INVESTIGATORS FUNDED BY THE NATIONAL INSTITUTES OF HEALTH AND OTHER PRIVATE FOUNDATIONS WHICH IS FOCUSED ON IDENTIFYING GENES ASSOCIATED WITH THE DEVELOPMENT OF DEMENTIA. THE FOUNDATION CONTINUES ITS SEARCH FOR A BIOTECH PARTNER TO SUPPORT RESEARCH AND DEVELOPMENT OF A PROMISING NEURODEGENERATIVE DISEASE TREATMENT UNDER DEVELOPMENT BY THE FOUNDATION.Expenses $4,103,203
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 20-3654626
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2007
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H96)
- Assets (IRS master file)
- $10,216,177
- Income (IRS master file)
- $7,965,326
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $7,965,326 | $7,076,763 | $10,216,177 | XML |
| 990 | December 2024 | $7,006,538 | $6,491,048 | $9,028,494 | XML |
| 990 | December 2023 | $8,795,245 | $7,305,106 | $6,996,425 | XML |
| 990 | December 2022 | $7,532,149 | $5,849,247 | $5,981,949 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-3654626).
Questions about REGENERATIVE RESEARCH FOUNDATION
- What is the EIN of REGENERATIVE RESEARCH FOUNDATION?
- The employer identification number (EIN) of REGENERATIVE RESEARCH FOUNDATION is 20-3654626.
- Is REGENERATIVE RESEARCH FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
- Are donations to REGENERATIVE RESEARCH FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does REGENERATIVE RESEARCH FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of REGENERATIVE RESEARCH FOUNDATION due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did REGENERATIVE RESEARCH FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of REGENERATIVE RESEARCH FOUNDATION?
- The 990 for the year ended December 31, 2025 names WILLIAM KAHN CPA.
- Who are the officers and directors of REGENERATIVE RESEARCH FOUNDATION?
- The 990 for the year ended December 31, 2025 lists 13 people; 7 received compensation from the organization, the highest $170,986 (SALLY TEMPLE-STERN PHD, EXECUTIVE & SCIENTIFIC DIRECTOR).
- How much revenue does REGENERATIVE RESEARCH FOUNDATION have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $7,965,326, expenses of $7,076,763 and total assets of $10,216,177 at year end.
Other nonprofits in ALBANY
- NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY EIN 20-5543641 · last filed 990 for 2024
- HEALTH CARE SYSTEMS RESEARCH NETWORK EIN 88-1934034 · last filed 990 for 2025
- MYT1L PROJECT FOUNDATION INC EIN 33-3912998 · last filed 990 for 2025
- PEDIATRIC NEUROCRITICAL CARE RESEARCH GROUP INC EIN 92-0252695 · last filed 990-EZ for 2025
- 360 WHITEHALL HOUSING DEVELOPMENT FUND CORP EIN 14-1800103 · last filed 990-PF for 2024
- ZC4H2 RESEARCH FOUNDATION INC EIN 87-4577599 · last filed 990-N for 2024
- ALBANY MEDICAL CENTER GROUP ORGANIZATION EIN 47-3869194 · last filed 990 for 2024
- RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK EIN 14-1368361 · last filed 990 for 2025